We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | NASDAQ:CYCN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.135 | 4.79% | 2.955 | 1.14 | 3.20 | 3.13 | 2.70 | 2.81 | 1,680 | 21:05:29 |
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Massachusetts | 83-1895370 | |
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
245 First Street, 18th Floor,
Cambridge, Massachusetts
|
|
02142
|
(Address of principal executive offices) | (Zip Code) |
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, no par value
|
|
CYCN
|
|
The Nasdaq Stock Market LLC
(Nasdaq Global Select Market)
|
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
|
|
|
Non-accelerated filer
☒
|
|
Smaller reporting company ☒
|
|
|
|
|
|
Emerging growth company ☒
|
Item 6. |
Exhibits
|
Exhibit
No.
|
Description
|
Certificate of Chief Executive Officer (Principal Executive Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Certificate of Chief Financial Officer (Principal Financial Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
Inline XBRL Instance Document
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
Cover Page Interactive Data File
|
|
CYCLERION THERAPEUTICS, INC.
|
|
|
|
|
|
By:
|
/s/ Peter M. Hecht
|
|
Name:
|
Peter M. Hecht
|
|
Title:
|
Chief Executive Officer (Principal Executive Officer)
|
|
|
|
|
By:
|
/s/ Anjeza Gjino
|
|
Name:
|
Anjeza Gjino
|
|
Title:
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
1 Year Cyclerion Therapeutics Chart |
1 Month Cyclerion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions